Archive

29 Jul

Conference Home II

by

in

by

in

ANANDA Scientific and NYU Grossman School of Medicine Announce First Patient enrolled in the Clinical Trial for Opioid Sparing in Participants with Radiculopathic Pain.
ANANDA Scientific Announces FDA approval of the IND for the Clinical Trial on the Treatment of Opioid Use Disorder (OUD)
ANANDA Scientific’s Liquid Structure™ Cannabidiol (CBD) to be clinically evaluated for Opioid Use Disorder.
ANANDA Scientific and the David Geffen School of Medicine UCLA Announce a Clinical Trial Utilizing Liquid StructureTM Cannabidiol (CBD) for the Treatment of Opioid Use Disorder (OUD).
ANANDA Scientific and NYU Grossman School of Medicine Announce First Patient Enrolled in the Clinical Trial Evaluating Liquid Structure™ Cannabidiol (CBD) for Treatment of Post-Traumatic Stress Disorder (PTSD)

Ananda Scientific was very pleased to host its Annual Shareholders’ Meeting this week. The shareholders were provid… https://t.co/d0cordFX8J

1 week ago
We have reached an impressive milestone with 6 ongoing FDA approved Clinical Trials for PTSD, Opioid Use Disorder,… https://t.co/C13X8yERjq

2 weeks ago
Ananda Scientific has one core mission: To pioneer high caliber #clinical studies to evaluate some the most debilit… https://t.co/2xOW15pJs8

3 weeks ago